Cereplast Announces Algaeplast(TM), Inc
EL SEGUNDO, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Cereplast, Inc. (OTCQB:CERP) (the "Company"), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, today announced the incorporation of a new wholly owned subsidiary, Algaeplast™, Inc. Algaeplast' s focus will be the development and manufacture of algae-based bioplastics. Cereplast has been a pioneer in algae-based plastics, helping to bring the first products made from Cereplast Algae Bioplastics™ grades to market in 2011, and with the recent commercialization of Biopropylene ® 109D in December of 2012.
Cereplast introduced the concept in late 2009, with a target of reaching a bioplastic made from 50% algae bio-content. Algaeplast's ultimate goal is to bring to market new polymers made from 100% algae content. Recently, the Company commercialized small quantities of Biopropylene 109D, a compound with 20% post-industrial algae biomatter. The research and development team is currently developing a grade with a higher percentage of algae bio-content. Based on customer interest, the Company has determined that the demand for bioplastics made from algae is significant, and therefore has created Algaeplast, which will focus on this new sector. Algaeplast has been created to develop a new monomer and polymers made from algae.
Mr. Frederic Scheer, Chairman and CEO of Cereplast, stated, "With recent developments made in the algae-to-oil process, the company believes it will reach its goal within less than 5 years, either solely or in partnership with other significant players in the field."Recently, Cereplast announced that it uses a post-industrial process that significantly reduces the odor that is normally inherent to algae biomatter, eliminating customer concerns about working with the material. Additionally, the Company uses algae biomass byproducts from algae biofuels and nutritionals that do not rely on the commercialization of biofuel production. These advancements fostered the commercialization of the Cereplast Algae Bioplastics product line earlier than expected.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts